Why are Bitcoiners fascinated with Semler Scientific Stock [SMLR]?

If you were to try to think of any companies putting bitcoin on their balance sheets, you’d picture tech startups or cryptocurrency-native businesses, but not necessarily a small, publicly traded healthcare business.

That’s what makes Semler Scientific (NASDAQ: SMLR) so interesting. Known primarily for medical diagnostic tools serving the medical industry, the company made waves in 2024 by not only adding bitcoin to its treasury, but also making bitcoin their main reserve asset.

The move took many by surprise, but bitcoin is neither a gimmick nor a one-off investment for Semler. Incorporating bitcoin represents a complete shift in corporate thinking—led by one man who believes that bitcoin isn’t just a financial asset but a tool that could reshape how businesses think about value.

What Semler Scientific Actually Does

Before diving into how bitcoin fits into the story, we first need to learn as to what Semler Scientific actually does (i.e. what exactly is their business model?).

Semler is a California-based medtech company, focused on early detection of chronic diseases. Their main product is QuantaFlo®, a test used to diagnose Peripheral Arterial Disease (PAD)—a condition that often goes unnoticed, especially in older adults. The test is quick, non-invasive, and can be used right in your doctor’s office. QuantaFlo® helps clinicians catch problems, and early detection means better outcomes for patients and lower healthcare costs for everyone.

Over the years, Semler has grown steadily. Nothing flashy—just strong, consistent performance in their own niche within the healthcare industry.

Then in 2024, Bitcoin entered the chat.

Erik Semler Steps In and Shifts the Conversation

The turning point came when longtime investor and board member Erik Semler started impacting the company’s direction to greater degrees. No stranger to the world of tech and finance, over time he started to make the case internally that Semler Scientific should start holding bitcoin.

At first, the idea seemed a bit … out there. Why would a healthcare company with absolutely zero connection to the cryptocurrency realm need bitcoin on its balance sheet?

Erik was not pitching bitcoin as a trendy move, though. Rather, he viewed bitcoin as a logical hedge in a world where traditional currencies were losing purchasing power. Bitcoin’s fixed supply and decentralized structure meant bitcoin offered a long-term way to protect the company’s reserves from inflation and fiat uncertainty.

Over several months, he worked behind the scenes to educate the board and executives, sharing data, walking the team through bitcoin’s fundamentals, and framing bitcoin not as speculation but as a modern approach to capital preservation.

By May 2024, Erik had made and won his case, and the board signed on.

The First Bitcoin Purchase—and What Followed

In May 2024, Semler Scientific officially announced its purchase of 581 bitcoin for around $40 million. In doing so, Semler declared bitcoin to be its primary treasury reserve asset. In the statement, the company cited bitcoin’s durability, scarcity, and global adoption as reasons for the bold move.

This wasn’t a marketing stunt. The purchase came from cash reserves. No gimmicks. Just bitcoin on the books.

Over the next few months, they didn’t stop there. By the end of 2024, the company increased its bitcoin holdings to 3,192 BTC. The returns were immediate: the value of that bitcoin more than doubled before the year was out.

For a small-to-mid cap company, that kind of treasury performance was hard to ignore.

Why It’s a Big Deal for Bitcoin

This wasn’t Strategy (formerly MicroStrategy) nor a VC-backed fintech startup. Semler was a company laser-focused on real-world healthcare, battling in the trenches through insurance, regulation, and compliance challenges. Companies like that do not make offbeat moves lightly.

That’s why this moment stood out. It showed that bitcoin’s appeal is widening, that its narrative is evolving. No longer is bitcoin just about “digital gold” or price speculation: bitcoin has become a valid option for treasury strategy, even in sectors far removed from cryptocurrency.

May 2024 also signaled to the world that education works. Erik Semler didn’t push this through overnight. He helped his company peers understand bitcoin as a hedge, not hype, and one that could quietly outperform the markets in this turbulent financial world.

Erik Semler’s Bitcoin Thesis

Erik Semler’s approach is not flashy, but consistent. Often, he speaks of how Bitcoin’s fundamentals line up with long-term value creation, citing its fixed supply, global accessibility, transparency, and resilience.

But more than that, he’s hinted at something deeper: a belief that Bitcoin’s ethos of openness, decentralization, and independence are all benefits to offer companies, not just investors.

In one of his statements, he suggested that just as QuantaFlo® empowers clinicians to make earlier diagnoses, Bitcoin empowers companies to take more control of their financial future, rather than relying on central banks or fiat systems that no longer behave predictably.

What About the Critics?

Of course, not everyone loved the move.

Some analysts questioned the wisdom of putting volatile assets on the books. Others said a healthcare company should not be dabbling in Bitcoin. Semler Scientific’s leadership was clear, however, that its core mission had not changed. The company would still build diagnostic tools, and still remain laser-focused on improved patient outcomes.

The Bitcoin strategy is not a pivot, rather a layer added to Semler’s treasury management, which is aimed not at replacing the business model but at strengthening the balance sheet.

So far, it’s working.

Where Does SMLR Go from Here?

Looking forward, Semler has not yet ruled out adding more bitcoin to the treasury if conditions are favorable. They have not yet announced plans for accepting payments in bitcoin, either, or building anything blockchain-based, but the door is now open.

What’s clear is that the company is in no way treating bitcoin as a temporary play: it’s now part of their long-term corporate financial identity.

The implications reach far beyond Semler to many other companies watching from the sidelines—especially those sitting on lots of cash that is losing value to inflation and are in need of a profitable alternative.

Final Thoughts: Bitcoin Quietly Making Its Way Into the Financial Mainstream

Semler Scientific might not be a name you associate with Bitcoin, but maybe now it should be.

A small company doing something surprisingly forward-thinking, Semler is using bitcoin to strengthen its position in this shaky economy, and is trusting in the same long-term fundamentals Bitcoiners have believed in for years.

If you’re in the Bitcoin space, this story is worth keeping on your radar. It’s one of the clearest signs yet that Bitcoin is quietly and steadily starting to gain real traction outside of the industry and beyond just the usual suspects, one boardroom at a time.

‍